eMolecules acquires Specs Compound Handling

""

eMolecules has announced the acquisition of Specs Compound Handling, a provider of chemical compound management services to the life sciences industry.

eMolecules provides a digital chemical search engine, specialising in unique structures with delivery options from a global network of suppliers.

“Welcoming the highly reputable and talented Specs team into eMolecules represents a major milestone and opportunity for our companies and customers,” said Dr Niko Gubernator, CEO and President of eMolecules. “This acquisition accelerates eMolecules vision of delivering world-class capabilities that support the rapid transformation of chemicals into knowledge.”

Dr Johan Tijhuis, CEO of Specs, added: “We are excited to join forces with eMolecules and believe that the combination of our two teams will enhance our value to the drug discovery research community.”

eMolecules’ existing investors, including Avista Capital Partners, supported the transaction.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free